Abstract
The role of T-helper 17 cells (Th17) and regulatory T-cells (Tregs) in the pathogenesis of alopecia areata (AA) has not been clearly elucidated. B cell activating factor (BAFF) being a regulator of T cell activation could be involved in this pathologic process as well. The current study evaluated the expression of IL-17, IL-22, Foxp3 and BAFF in tissue and sera of AA patients. Forty AA patients and 40 age and sex matched healthy controls were included. Tissue and serum levels of IL-17, IL-22, BAFF as well as serum level of Foxp3 were measured by enzyme-linked immunosorbent assay (ELISA). Immunohistochemical staining was used for assessment of tissue level of Foxp3. Tissue and serum levels of IL-17, tissue levels of IL-22 and BAFF were significantly higher in patients. Serum levels of IL-22, Foxp3 and BAFF were non-significantly higher in patients. Foxp3 immunostaining showed negativity in tissue of patients and controls. A significant positive correlation was found between both tissue levels of IL-17 and BAFF (r = 0.474, P = 0.035) and tissue level of IL-22 and disease duration (r = 0.766, P < 0.001) in AA patients. Th17 cells and BAFF are synergistically involved in the pathogenesis of AA. BAFF represents a promising therapeutic target for such a challenging disease. Defective Tregs number and/or function in AA warrants further studies.
Similar content being viewed by others
References
Afzali B, Lombardi G, Lechler RI, Lord GM (2007) The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 148(1):32–46
Alli R, Nguyen P, Boyd K, Sundberg JP, Geiger TL (2012) Mouse model of clonal CD8+ T lymphocyte-mediated alopecia areata progressing to alopecia universalis. J Immunol 188(1):477–486. doi:10.4049/jimmunol.1100657 (epub 2011 Nov 23)
Ansel J, Perry P, Brown J, Damm D, Phan T, Hart C, Luger T, Hefeneider S (1990) Cytokine modulation of keratinocyte cytokines. J Invest Dermatol 94(6 Suppl):101S–107S
Arca E, Muşabak U, Akar A, Erbil AH, Taştan HB (2004) Interferon-gamma in alopecia areata. Eur J Dermatol 14(1):33–36
Basak PY, Adiloglu AK, Ceyhan AM, Tas T, Akkaya VB (2009) The role of helper and regulatory T cells in the pathogenesis of vitiligo. J Am Acad Dermatol 60(2):256–260. doi:10.1016/j.jaad.2008.09.048 (epub 2008 Nov 20)
Bodemer C, Peuchmaur M, Fraitaig S, Chatenoud L, Brousse N, De Prost Y (2000) Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol 114(1):112–116
Chen M, Lin X, Liu Y, Li Q, Deng Y, Liu Z, Brand D, Guo Z, He X, Ryffel B, Zheng SG (2014) The function of BAFF on T helper cells in autoimmunity. Cytokine Growth Factor Rev 25(3):301–305. doi:10.1016/j.cytogfr.2013.12.011 (epub 2013 Dec 24)
De Boer OJ, van der Loos CM, Teeling P, van der Wal AC, Teunissen MB (2007) Immunohistochemical analysis of regulatory T cell markers FOXP3 and GITR on CD4+ CD25+ T cells in normal skin and inflammatory dermatoses. J Histochem Cytochem 55(9):891–898 (epub 2007 May 3)
Garg S, Messenger AG (2009) Alopecia areata: evidence based treatments. Semin Cutan Med Surg 28(1):15–18. doi:10.1016/j.sder.2008.12.002
Gilhar A, Etzioni A, Paus R (2012) Alopecia areata. N Engl J Med 366(16):1515–1525. doi:10.1056/NEJMra1103442
Harries MJ, Sun J, Paus R, King LE Jr (2010) Management of alopecia areata. BMJ 341:c3671. doi:10.1136/bmj.c3671
Heo YJ, Joo YB, Oh HJ, Park MK, Heo YM, Cho ML, Kwok SK, Ju JH, Park KS, Cho SG, Park SH, Kim HY, Min JK (2010) IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients. Immunology Lett 127(2):150–156. doi:10.1016/j.imlet.2009.10.006 (epub 2009 Nov 4)
Huard B, Schneider P, Mauri D, Tschopp J, French LE (2001) T cell co-stimulation by the TNF ligand BAFF. J Immunol 167(11):6225–6231
Ito T, Ito N, Bettermann A, Tokura Y, Takigawa M, Paus R (2004) Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 164(2):623–634
Kolls JK, Lindén A (2004) Interleukin-17 family members and inflammation. Immunity 21(4):467–476
Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103(9):1345–1352
Krivosikova M, Dallos T, Maslinski W, Buc M (2009) B cell activating factor: its role in autoimmunity, and targeting in autoimmune diseases. Bratisl Lek Listy 110(3):137–145
Kuwano Y, Fujimoto M, Watanabe R, Ishiura N, Nakashima H, Ohno Y, Yano S, Yazawa N, Okochi H, Tamaki K (2008) Serum BAFF and APRIL levels in patients with alopecia areata. J Dermatol Sci 50(3):236–239. doi:10.1016/j.jdermsci.2008.01.004 (epub 2008 Mar 6)
Lai Kwan Lam Q, King Hung Ko O, Zheng BJ, Lu L (2008) Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc Natl Acad Sci USA 105(39):14993–14998. doi:10.1073/pnas.0806044105 (epub 2008 Sep 26)
Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201(2):233–240
Lew BL, Cho HR, Haw S, Kim HJ, Chung JH, Sim WY (2012) Association between IL17A/IL17RA gene polymorphisms and susceptibility to alopecia areata in the Korean population. Ann Dermatol 24(1):61–65. doi:10.5021/ad.2012.24.1.61 (epub 2012 Feb 2)
Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA (2006) Interleukin (IL)-22 and IL- 17 are coexpressed by TH17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203(10):2271–2279 (epub 2006 Sep 18)
Meyer KC, Klatte JE, Dinh HV, Harries MJ, Reithmayer K, Meyer W, Sinclair R, Paus R (2008) Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br J Dermatol 159(5):1077–1085. doi:10.1111/j.1365-2133.2008.08818.x (epub 2008 Sep 15)
Min WP, Zhou D, Ichim TE, Strejan GH, Xia X, Yang J, Huang X, Garcia B, White D, Dutartre P, Jevnikar AM, Zhong R (2003) Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol 170(3):1304–1312
Olsen EA, Hordinsky MK, Price VH, Roberts JL, Shapiro J, Canfield D, Duvic M, LE King Jr, McMichael AJ, Randall VA, Turner ML, Sperling L, Whiting DA, Norris D, National Alopecia Areata Foundation (2004) Alopecia areata investigational assessment guidelines—part II. National Alopecia Areata Foundation. J Am Acad Dermatol 51(3):440–447
Paus R, Arck P (2009) Neuroendocrine perspectives in alopecia areata: does stress play a role? J Invest Dermatol 129(6):1324–1326. doi:10.1038/jid.2009.111
Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y, Kim H, Singh P, Lee A, Chen WV, Meyer KC, Paus R, Jahoda CA, Amos CI, Gregersen PK, Christiano AM (2010) Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 466(7302):113–117. doi:10.1038/nature09114
Picardi A, Pasquini P, Cattaruzza MS, Gaetano P, Baliva G, Melchi CF, Papi M, Camaioni D, Tiago A, Gobello T, Biondi M (2003) Psychosomatic factors in first- onset alopecia areata. Psychosomatics 44(5):374–381
Sato-Kawamura M, Aiba S, Tagami H (2003) Strong expression of CD40, CD54 and HLADR antigen and lack of evide-nce for direct cellular cytotoxicity areunique immunohistopathological features in alopecia areata. Arch Dermatol Res 294(12):536–543 (epub 2002 Dec 3)
Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, Ambrose C, Lawton P, Bixler S, Acha-Orbea H, Valmori D, Romero P, Werner-Favre C, Zubler RH, Browning JL, Tschopp J (1999) BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cellgrowth. J Exp Med 189(11):1747–1756
Serada S, Fujimoto M, Mihara M, Koike N, Ohsugi Y, Nomura S, Yoshida H, Nishikawa T, Terabe F, Ohkawara T, Takahashi T, Ripley B, Kimura A, Kishimoto T, Naka T (2008) IL-6 blockade inhibits the induction of myelin antigen-specific Th17cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 105(26):9041–9046. doi:10.1073/pnas.0802218105 (epub 2008 Jun 24)
Shin BS, Furuhashi T, Nakamura M, Torii K, Morita A (2013) Impaired inhibitory function of circulating CD4+ CD25+ regulatory T cells in alopecia areata. J Dermatol Sci 70(2):141–143. doi:10.1016/j.jdermsci.2013.01.006 (epub 2013 Feb 4)
Sutherland AP, Ng LG, Fletcher CA, Shum B, Newton RA, Grey ST, Rolph MS, Mackay F, Mackay CR (2005) BAFF augments certain Th1-associated inflammatory responses. J Immunol 174(5):5537–5544
Tanemura A, Oiso N, Nakano M, Itoi S, Kawada A, Katayama I (2013) Alopecia Areata: infiltration of Th17 Cells in the dermis, Particularly around Hair Follicles. Dermatology 226(4):333–336. doi:10.1159/000350933 (epub 2013 Jul 4)
Tembhre MK, Sharma VK (2013) T-helper and regulatory T- cell cytokines in the peripheral blood of patients with active alopecia areata. Br J Dermatol 169(3):543–548. doi:10.1111/bjd.12396
Terras S, Gambichler T, Moritz RK, Altmeyer P, Lambert J (2014) Immunohistochemical analysis of FOXP3+ regulatory T cells in healthy human skin and autoimmune dermatoses. Int J Dermatol 53(3):294–299. doi:10.1111/j.1365-4632.2012.05808.x (epub 2013 Aug 22)
Tojo G, Fujimura T, Kawano M, Ogasawara K, Kambayashi Y, Furudate S, Mizuashi M, Aiba S (2013) Comparison of Interleukin-17 producing cells in different clinical types of Alopecia Areata. Dermatol 227(1):78–82. doi:10.1159/000353159 (epub 2013 Aug 30)
Verhagen J, Akdis M, Traidl-Hoffmann C, Schmid-Grendelmeier P, Hijnen D, Knol EF, Behrendt H, Blaser K, Akdis CA (2006) Absence of T- regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 117(1):176–183
Wang E, McElwee KJ (2011) Etiopathogenesis of alopecia areata: why do our patients get it? Dermatol Ther 24(3):337–347. doi:10.1111/j.1529-8019.2011.01416.x
Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM (2006) Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24(6):677–688
Lu W, Shapiro J, Yu M, Barekatain A, Lo B, Finner A, McElwee K (2006) Alopecia areata: pathogenesis and potential for therapy. Expert Rev Mol Med 8(14):1–19
Wolk K, Witte E, Wallace E, Döcke WD, Kunz S, Asadullah K, Volk HD, Sterry W, Sabat R (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36(5):1309–1323
Zhang B, Hu M, Zhang P, Cao H, Wang Y, Wang Z, Su T (2013) BAFF promotes regulatory T-cell apoptosis and blocks cytokine production by activating B cells in primary biliary cirrhosis. Braz J Med Biol Res 46(5):433–439. doi:10.1590/1414-431X20132665 (epub 2013 May 10)
Zhang Z, Li X, Guo J, Xu F, He Q, Zhao Y, Yang Y, Gu S, Zhang Y, Wu L, Chang C (2013) Interleukin-17 enhances the production of interferon-γ and tumour necrosis factor-α by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes. Eur J Haematol 90(5):375–384. doi:10.1111/ejh.12074 (epub 2013 Mar 1)
Zheng SG, Wang J, Horwitz DA (2008) Cutting edge: Foxp3+ CD4+ CD25+ regulatory T cells induced by IL-2 and TGF- beta are resistant to Th17 conversion by IL-6. J Immunol 180(11):7112–7116
Zhou X, Xia Z, Lan Q, Wang J, Su W, Han YP et al (2011) BAFF promotesTh17cells and aggravates experimental autoimmune encephalomyelitis. PLoS One 6(8):e23629. doi:10.1371/journal.pone.0023629 (epub 2011 Aug 29)
Zöller M, McElwee KJ, Engel P, Hoffmann R (2002) Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata. J Invest Dermatol 118(6):983–992
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding sources
None.
Conflict of interest
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Elela, M.A., Gawdat, H.I., Hegazy, R.A. et al. B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of Alopecia Areata. Arch Dermatol Res 308, 115–121 (2016). https://doi.org/10.1007/s00403-016-1617-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-016-1617-z